Mediwound Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.1% | +6.4% | -3.0% | +1.1% | +10.0% | -9.8% | +10.1% | +6.1% | +65.1% | -45.2% | +6.3% | – | |
| – | -4.2% | +71.8% | +48.0% | +38.0% | -21.4% | +2.7% | +2.1% | -14.2% | -10.5% | -2.7% | +17.2% | – | |
| – | – | -286.7% | – | – | +3,238.8% | -101.9% | – | – | +57.3% | -79.1% | -240.2% | – | |
| – | +31.1% | -43.0% | +139.6% | -60.5% | -32.4% | +19.0% | +9.4% | -0.4% | +134.6% | -25.8% | -41.5% | – | |
| – | – | -147.5% | – | -602.1% | – | -169.2% | – | -10.7% | -645.6% | – | -114.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -71.9% | +242.6% | -85.3% | – | -102.5% | -29.4% | – | +5,460.1% | -103.6% | -61.4% | – | – | |
| – | – | +809.7% | -103.8% | – | -0.2% | -390.9% | – | – | -188.2% | – | -481.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.